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ABSTRACT
The present work aims to study powder microscopy, physicochemical and high-performance thin-layer
chromatography photo documentation and fingerprint profiles of a Siddha drug, Rattha Piththathirku
Kudinir Chooranam (RPK). The raw drugs were collected, authenticated and the RPK was prepared.
Then the drug was investigated for powder microscopic characters, physicochemical parameters, Thin
Layer  Chromatographic  photo documentation (TLC),  High-Performance Thin-Layer  Chromatographic
(HPTLC)  fingerprint  profiles  of  successive  n-hexane,  successive  chloroform,  successive  ethanol  and
hydro alcohol (1:1) extracts. The successive and hydro alcohol extracts of the drug displayed distinct
TLC spots and HPTLC peaks which are distinct to this drug.
Introduction
Hypertension is a major health issue that leads to an
increase in the risks of heart, brain, kidney and other
organ related diseases. It is one of the major reasons
for early death of public (1). According to the World
Health  Organization,  it  is  estimated  that  1.13 billion
people  are  suffering  from  hypertension  worldwide,
and  two-thirds  of  them  belong  to  low  and  middle
income countries (2). Traditional and complementary
medicine plays an important role in maintaining good
health due to its easy acceptance by the human body
(3) and lesser side effects. Among 170 Member States
of WHO, 88% recognised their use of traditional and
complementary  medicine  (4). Rattha Pitthathirku
Kudinir (RPK)  is  a  Siddha  drug  consisting  of  cukku
[Zingiber  officinale  Linn.  (rhizome)] and  caranai
[Zaleya  decandra  (L.)  Burm.  (root)].  Ratthapitham
refers  to  Purpura i.e.  hypertension.  According  to
Siddha literature,  30 to 60 ml of medicine has to be
taken twice daily for treating hypertension (5).
The  plant  Zaleya  decandra  is  commonly  called
Purslane (English)  and belongs to  Aizoaceae  (6). It is
native  to  India,  Sri  Lanka  and  Australia  and
introduced  to  tropical  regions  of  Africa  and  South
America (7,  8).  Traditionally the root is used for the
treatment  of  hepatitis,  asthma  and  orchitis  (9).
Decoction of root bark is well known as an aperient
(10).  The  preliminary  qualitative  phytochemical
screening  has  been  reported  (6)  to  show  alkaloids,
carbohydrates,  phenols,  terpenoids,  cardiac
glycosides, fatty acids, saponins, tannins and proteins.
GC-MS  analysis  of  Z.  decandra revealed  that
momeinositol  (26.57%),  methyl  ester  of  2-hydroxy-
valeric acid (18.9%), 2-methyl-hexanoic acid,  (7.74%),
2-amino-5-(2-carboxy)vinyl)  imidazole,  (7.71%),
decanoic  acid  (7.45%),  allantoic  acid  (6.90%)  are
present in major concentrations; whereas dl-citrulline
(3.8%),  benz(e)azulene-3,8-dione,  octanoic  acid
(2.16%),  1,3-dioxolan-4-one,  strogogenin  (1.04%),
12,15-octadecatrienoic  acid,  n-hexadecanoic  acid
(0.89%), 1H-pyrazole, 4,5-dihydro-3-methyl- (0.66%), E-
11-tetradecenol,  trimethylsilyl  ether  (0.59%)  and
malonic acid were reported to be present in minimal
concentrations (7). Oleic acid has been isolated from
the  root  of  Z.  decandra  (11). Pharmacologically  it
shows antidiabetic (12), hepatoprotective, antioxidant
(13), cytotoxic activity (7) and anthelmintic activity (6).
Zingiber oficinale is used in several ancient systems
of medicines for the treatment of catarrh, rheumatism,
nervous diseases,  gingivitis,  toothache,  asthma,  stroke,
diabetes, headache, gastrointestinal discomforts, nausea,
vomiting  and  the  common  cold (14-16).  Traditionally
ginger is being administered for hypertensive patients
since  ancient  days  (17).  It  consists  of  volatile  oils,
gingerol, diarylheptanoids, proteins, amino acids, sugar,
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organic  acids  and  inorganic  elements.  It  comprises
more than 300 types of compounds, mainly categorised
into  3  different  types:  194  types  of  volatile  oil
compounds,  85  types  of  gingerols  and  28  types  of
diarylheptanoids (18). The major phytoconstituents of
Z.  officinale  are  6-shogaol,  6-gingerol,  8-gingerol,  10-
gingerol, zingiberol,  β-phellandrene,  α-zingiberene,  ar-
curcumene  and  β-bisabolene  along  with  the
compounds  gingerdiols,  α-santalol,  β-eudesmol,
nerolidol,  farnesol,  elemol,  neral,  geranial,  α and β-
pinene, camphene, sabinene, myrecene and limonene
(18-24). Pharmacological  actions  of  ginger  are  anti-
diabetic,  anti-inflammatory,  analgesic,  antimicrobial,
tissue  and  radio-protective,  anti-emetic,  anti-
tumorigenic  and  antioxidant  effects  (25). The
hypertensive effect and antiplatelet effect of Z. officinale
have been well registered. The study of fresh ginger in
anaesthetised rats exhibited a blood pressure lowering
effect,  possibly  through  a  specific  blockade  of  the
voltage-dependent Ca2+ channels  (26). The study of  Z.
officinale on  the  pharmacodynamic  and
pharmacokinetic  of  losartan  in  hypertensive  rats
divulged the hypertension management effect of it (27).
As hypertension is a common illness, and there
are  medications  available  in  several  brand  names;
thus quality control parameters are required for the
analysis of commercial samples. Hence, it is decided
to evaluate the powder microscopic, physicochemical
values, document thin layer photography and record
the HPTLC fingerprint profiles.
Materials and Methods
Plant material
Zaleya decandra  root and Zingiber oficinale  rhizome
were collected from the Survey of Medicinal  Plants
Garden, Mettur, Tamil Nadu and were authenticated
by referring floras and chemical test.
Formulation of RPK
The  rhizome  of  Zingiber  officinale and  the  roots  of
Zaleya decandra were washed well  in running water
and  then  shade  dried.  The  dried  samples  were
powdered  and  passed  through  a  sieve  no.  60.  The
powdered drugs were mixed thoroughly in the ratio of
1:1 (5). 
Powder Microscopy
A pinch of the mixed powdered sample was mounted
on a microscopic slide  with a drop of  50% glycerol
after treating it with 0.1 % chloral hydrate solution.
Characters were observed using Nikon ECLIPSE E200
trinocular  microscope  attached  with  Zeiss  ERc5s
digital  camera  under  bright  field  light.
Photomicrographs  of  diagnostic  characters  were
captured and documented (28).
Physico-chemical Analysis
All the physicochemical parameters were evaluated
according to the standard methods (28).
Chemicals, Solvents and Instruments
Analytical  grade  solvents  n-hexane,  toluene,
chloroform,  ethyl  acetate,  ethanol,  methanol  and
formic acid were purchased from Merck. Vanillin (1
gm) sulphuric acid in methanol (5%) solution (VSR)
was used for visualisation. For HPTLC, Autosampler
ATS4,  twin  trough  chambers,  visualiser,  scanner  4
(Scanner_210441)  linked  with  WINCATS  software,
plate  heater  (all  from  CAMAG,  Switzerland)  were
used. 
Extract Preparation
RPK  (4  gm)  was  subjected  to  successive  extraction
with  100  ml  of  each  of  n-hexane,  chloroform  and
ethanol  using  Soxhlet  apparatus.  Extracts  were
concentrated to dryness. The total residues were re-
solvated with the corresponding solvents and made
up to 10 ml, and transferred into sample vials for TLC
application.  For  hydro alcohol  extract,  1  gm of  the
drug was refluxed with 25 ml of aqueous ethanol (1:1
ratio) for 2 hrs, cooled, filtered and used for TLC in
the sample vial.
HPTLC analysis
Successive n-hexane, chloroform and ethanol extract,
10 μl each, were applied on three different silica gel
60F254 pre-coated aluminium plate  (6 × 10 cm) as  8
mm  band  10  mm  from  the  bottom.  The  plate
containing  n-hexane  extract  was  developed  using
toluene:  ethyl  acetate:  formic  acid  (8:  2:  0.5,  v/v/v),
chloroform extract plate using toluene: ethyl acetate:
formic acid (6.0:4.0:1.0,  v/v/v) and ethanol extract by
using toluene: ethyl acetate :  methanol:  formic acid
(3.0:4.0:3.0:  0.5,  v/v/v/v)  separately  in  pre-saturated
twin  trough  chamber  (10  ×  10  cm).  The  developed
plates  were  dried,  and  photographs  were  taken
under  UV,  followed  by  scanning  under  λ  254
(absorbance mode, D2 lamp) and λ 366 (fluorescence
mode, Hg lamp) respectively with a slit dimension 6 ×
0.45  mm  and  scanning  speed  of  20  mm/s.  The
scanned  plates  were  dipped  in  VSR  and  heated  at
105°C  till  the  appearance  of  coloured  bands.
Photographs were taken immediately at white light,




The  powder  microscopic  observation  showed  the
following  characters,  Zingiber  officinale: suberised
cork;  scalariform  and  pitted  vessels;  septate  non
lignified  fibre;  oleoresin  and  sac  shaped  starch
grains;  Zaleya  decandra: thick-walled  cork  cells,
fibrous  layers,  crystal  fibres,  pitted  vessels,  spiral
vessels and heterogenous prismatic crystals (Fig. 1).
The powder is pale yellow with a characteristic odour
and taste. 
Microscopic  examination  of  the  powdered
compounded formulation revealed suberised cork,
oleoresin  and  sac  shaped  starch  grains  which
form  the  diagnostic  characteristics  of  Zingiber
officinale  rhizome  and thick-walled  cork  cells,
crystal  fibres  together  with  heterogenous
prismatic  crystals  could  be  attributed  to  Zaleya
decandra root. Each species has its own diagnostic
character,  which  can  be  used  to  confirm  its
identity.  In  the  present  study,  the  powder
microscopic  characterisation  of  the  compound
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formulation  has  led  to  the  effective  diagnosis  of
the individual herbal drugs used in it. 
Physicochemical results
The  physicochemical  values  of  the  tested  drug  are
presented  in  Table  1.  Drug  quality  is  markedly
affected  by  moisture  content  denoted  by  loss  on
drying  (LOD),  which  alters  the  shelf  life  of  herbal
drug. LOD value was found to be 10.38 ± 0.17 %. Total
ash value was determined as 6.87 ± 0.09 %. Total ash
contains  physiological  and  non-physiological
inorganic  salts  of  phosphates,  silicates  and
carbonates. Acid insoluble ash (AIA) value represents
the amount of earthing matters present in roots and
rhizomes.  AIA  was  found  to  be  1.43  ±  0.09%.  The
alcoholic soluble extractive value was estimated as 17
± 0.15%, whereas the water-soluble extractive value
was  12.26  ±  0.16  %.  The  pH  of  the  drug  was
determined as 4.62, which revealed the acidic nature
of  the  drug.  The  physicochemical  values  of  any
herbal  drug  would  vary  and  the  same  could  be
considered for the quality control of drugs (29-31). 
TLC Photo documentation
In the TLC photo documentation of n-hexane extract
of  RPK  (Supplementary  Fig.  1),  8  bands  were
visualized  with  Rf  0.11,  0.25,  0.28,  0.33,  0.41,  0.52,
0.67  and  0.73  (all  green)  under  short  UV;  8  bands
Suberised cork of Z. officinale Scalariform vessels of Z. officinale Pitted vessel of Z. officinale
Septate non lignified fibre of Z. officinale Oleoresin of Z. officinale Starch grains of Z. officinale
Cork cells of Z. decandra Fibrous layer of Z. decandra Crystal fiber of Z. decandra
Pitted vessel of Z. decandra Spiral vessels of Z. decandra Prismatic crystals of Z. decandra
Fig. 1. Powder Microscopy of Rattha Piththathirku Kudinir Chooranam.





Loss on drying (105°C) (%) 10.38 ± 0.17
Total ash (%) 6.87 ± 0.09
Acid insoluble ash (%) 1.43 ± 0.09
Water-soluble extract (%) 12.26 ± 0.16
Alcohol soluble extract (%) 5.17 ± 0.15
pH (10 % solution) 4.62 ± 0.01
PLANT SCIENCE TODAY  606
were visualized with Rf 0.08 (blue), 0.12 (green), 0.18
(blue),  0.25  (green),  0.34  (red),  0.50  (violet),  0.58
(blue)  and 0.77 (blue) under long UV and 10 bands
were  visualized with  Rf 0.04  (violet),  0.10  (violet),
0.24 (violet),  0.28 (violet),  0.34 (red), 0.45,  0.69 and
0.77 (all violet). 
The  photo  documentation  of  successive
chloroform extract  (Supplementary  Fig.  2)  revealed
6 bands with Rf  0.03, 0.42, 0.48,  0.54, 0.60 and 0.76
(all  green)  under  short  UV;  6  bands  with  R f 0.05,
0.23, 0.40, 0.44, 0.54 (all blue) and 0.72 (fluorescent
blue) under long UV and 7 bands with 0.03 (brown),
0.23, 0.25, 0.42, 0.52, 0.63 and 0.83 (all violet) under
white light post derivatization. 
In  the  successive  ethanol  extract  of  RPK
(Supplementary  Fig.  3),  7  bands  with  Rf  0.04,  0.09,
0.20, 0.28, 0.47, 0.67 and 0.77 (all green) under short
UV;  9  bands with  Rf 0.04,0.09,  0.21,0.24,  0.31,  0.45,
0.53,  0.66 and 0.82 (all  blue)  under long UV and 6
bands  for  post  derivatized  plate  under  white  light
with 0.05, 0.11, 0.47 (brown), 0.66, 0.72, 0.79 (violet)
were observed. 
TLC  photo  documentation  of  hydro-alcohol
extract  of  RPK  (Supplementary  Fig.  4)  showed  5
bands  with  Rf 0.09,  0.14,  0.52,  0.66  and  0.70  (all
green) under short UV; 5 bands under long UV with
Rf 0.16  (blue),  0.59  (blue),  0.66  (blue),  0.67  (light
green)  and  0.82  (blue)  and  6  bands  with  Rf 0.06
(black),  0.12 (black),  0.29 (black),  0.52 (green),  0.67
(violet)  and  0.70  (violet)  under  white  light  post
derivatization.
HPTLC Densitometry
Scanning of plate developed using  n-hexane extract
of  RPK  (Supplementary  Fig.  1)  divulged  13  peaks
with  Rf 0.11  (area  10.88%),  0.19  (1.96%),  0.25
(13.64%),  0.28  (8.00%),  0.33  (6.45%),  0.41  (5.06%),
0.52  (11.32%),  0.59  (6.64%),  0.67  (11.84%),  0.73
(19.92%), 0.87 (1.67%), 0.89 (2.16%) and 0.97 (0.46%)
under short UV; 12 peaks under long UV with Rf 0.08
(3.84%), 10 (1.89%),  0.12 (2.28%), 0.14 (1.85%), 0.18
(4.00%),  0.25 (22.78%),  0.34  (48.84%),  0.50  (1.56%),
0.58  (9.86%),  0.77  (0.56%),  0.83  (0.16%)  and  0.93
(2.39%)  and  12  peaks  with  Rf 0.04  (1.29%),  0.10
(12.62%),  0.24  (8.59%),  0.28  (4.99%),  0.34  (10.13%),
0.45  (13.00%),  0.53  (7.33%),  0.69  (16.47%),  0.77
(24.88%), 0.91 (0.21%), 0.96 (0.25%) and 0.98 (0.23%)
under white light post derivatization. 
For  successive  chloroform  extract
(Supplementary  Fig.  2)  9 peaks were detected with
Rf 0.01  (1.08%),  0.03  (1.51%),  0.20  (0.26%),  0.42
(27.34%), 0.48 (10.30%), 0.53 (13.29%), 0.60 (26.21%),
0.76 (19.40%) and 0.94 (0.62%) under  short  UV; 10
peaks  with  Rf 0.06  (1.18%),  0.23  (1.30%),  0.28
(1.06%), 0.40 (7.03%), 0.44 (4.56%), 0.49 (2.86%), 0.54
(5.74%),  0.71  (74.39%),  0.80  (1.42%),  0.86  (0.45%)
under long  UV and  13 bands with Rf 0.01 (0.76%),
0.03 (0.80%), 0.06 (0.13%), 0.15 (0.24%), 0.23 (3.77%),
0.25  (1.92%),  0.35  (10.91%),  0.42  (16.23%),  0.46
(6.09%), 0.52 (13.84%), 0.63 (23.29%), 0.83 (20.68%)
and  0.93  (1.36%)  under  white  light  post
derivatization. 
Successive ethanol extract (Supplementary  Fig.
3) showed 8 peaks with Rf 0.04 (0.14%), 0.09 (1.02%),
0.17  (1.01%),  0.20  (2.66%),  0.28  (7.95%),  0.47
(26.62%),  0.67  (41.41%)  and  0.76  (19.19%)  under
short UV; 13 peaks with Rf 0.01 (1.70%), 0.04 (2.08%),
0.09 (0.39%), 0.13 (0.59%), 0.21 (3.61%), 0.24 (1.98%),
0.31  (12.25%),  0.45  (2.74%),  0.53  (5.07%),  0.66
(53.74%), 0.82  (14.37%),  0.95  (0.95%)  and  0.97
(0.55%)  under  long  UV  and  9  peaks  with  Rf 0.01
(3.83%),  0.05  (9.72%),  0.11  (20.84%),  0.26  (0.46%),
0.47  (9.43%),  0.66  (22.30%),  0.72  (6.39%),  0.79
(17.15%)  and  0.89  (9.88%)  in  white  light  post
derivatization.
Scanning  of  hydro-alcohol  extract
(Supplementary  Fig.  4) of revealed 11 peaks with R f
0.01 (area 13.59%),  0.09 (2.54%),  0.14 (0.48%),  0.17
(0.95%), 0.24 (3.96%), 0.26 (6.23%), 0.34 (0.71%), 0.52
(22.87%),  0.66  (31.70%),0.70  (13.75%)  and  0.79
(3.22%) under short UV;  11 peaks with Rf  0.02 (area
48.05%),  0.08  (3.30%),  0.11  (1.18%),  0.16  (11.53%),
0.20 (1.26%), 0.59 (8.85%), 0.66 (9.52%), 0.67 (9.80%),
0.82  (5.63%),  0.96  (0.35%)  and  0.97  (0.51%)  under
long UV and 12 peaks with Rf 0.01 (area 6.28%), 0.06
(10.88%),  0.12  (22.52%),  0.29 (6.39%),  0.34  (3.18%),
0.52  (13.57%),  0.67  (20.84%),  0.70  (11.70%),  0.79
(2.89), 0.87 (0.45), 0.88 (0.93) and 0.95 (0.38%) under
white light post derivatization.
Scanning  of  n-hexane  extract  of  RPK  revealed
major peaks at Rf  0.73 (area 19.92%), 0.25 (13.64%)
and 0.67 (11.84%) under short UV; at  Rf 0.34 (area
48.84%),  0.25(22.78%)  and 0.58 (9.76%) under  long
UV; and peaks at Rf 0.77 (area 24.88%), 0.69 (16.47%)
and 0.45 (13.00%) under white light scanning of post
derivatized plate. Scanning of successive chloroform
extract  revealed  prominent  peaks  Rf  0.42  (area
27.34%), Rf  0.60 (26.21%) and Rf 0.76 (19.40%) under
short UV; peaks Rf 0.71 (area 74.39%), Rf 0.40 (7.03%)
and 0.44 (4.56%) under  long UV and peaks Rf  0.63
(area 23.29%),  Rf 0.83 (20.68%) and Rf  0.42 (16.23%)
under white  light  of  post  derivatized plate.  Finger
print  profile  of  successive ethanol  extract  exposed
major peaks Rf  0.67 (area 41.41%), Rf  0.47 (26.62%)
and Rf  0.76 (19.19%) under short UV,  peaks Rf  0.66
(area 53.74%), Rf 0.82(14.37%) and Rf  0.31 (12.25%)
under  long  UV  and  peaks  Rf  0.66  (22.30%),  Rf
0.11(20.84%) and Rf 0.79 (17.15%) under white light
of post derivatized plate.
Densitometric  scan of hydro-alcohol  extract  of
RPK  divulged  paramount  peaks  Rf 0.66  (area
31.70%), Rf 0.52(22.87%) and Rf 0.70 (13.75%) under
short UV, peaks Rf 0.02 (48.05%), Rf 0.16 (11.53%) and
Rf 0.66(9.52%) under long UV and peaks Rf 0.12 (area
22.52%), Rf 0.67 (20.84%) and Rf 0.52 (13.57%) under
white light of post derivatized plate. The TLC/HPTLC
of  successive  hexane,  chloroform,  ethanol  would
reveal  the  presence  of  a  number  of
phytoconstituents  which  are  low  polar,  medium
polar and high polar respectively (32-34).
Conclusion
The  powder  microscopic  characters,  TLC/HPTLC
photos and fingerprint profiles are distinct to Rattha
Piththathirku Kudinir Chooranam and the same could
be  applied  for  the  quality  control  of  the  drug  as
pharmacopoeial reference standards.
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